Keyphrases
Vaccination
100%
Nonhuman Primate
100%
Cross-protection
100%
COVID-19
100%
Common Cold Coronaviruses
100%
Fowl Adenovirus (FAdV)
100%
Human Coronavirus 229E
60%
Coronavirus
60%
Viral Shedding
60%
Recombinant
40%
Lung Tissue
40%
Histological Analysis
40%
Cynomolgus Macaque
40%
Spike Protein
40%
Inflammation
20%
Age of Infection
20%
Mouse Model
20%
Vaccination Strategy
20%
Infectious Virus
20%
Clinical Signs
20%
Adenovirus Vaccine
20%
Unvaccinated
20%
Novel Coronavirus
20%
Infection Model
20%
Moderate Disease
20%
Multiple Time Points
20%
Intranasal Route
20%
Coronavirus Vaccine
20%
Alphacoronavirus
20%
Human Coronavirus OC43
20%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
20%
Human Coronavirus NL63
20%
K18-hACE2 Mice
20%
Severe Acute Respiratory Syndrome coronavirus-2 Vaccine
20%
Cross-reactive Immune Response
20%
Lung Burden
20%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
100%
Common Cold
100%
Infection
80%
Human Coronavirus 229E
60%
Diseases
60%
Coronavirinae
40%
Macaca fascicularis
40%
Fowl
40%
Mouse Model
20%
Inflammation
20%
Virus Infectivity
20%
Adenoviridae
20%
Intranasal Route
20%
Adenovirus Vaccine
20%
Human Coronavirus NL63
20%
K 18
20%
Alphacoronavirus
20%
Human Coronavirus OC43
20%
Lung Burden
20%
Immunology and Microbiology
Coronavirus
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Cross Protection
100%
Infection
57%
Human Coronavirus 229E
42%
Viral Shedding
42%
Coronavirinae
28%
Spike
28%
Macaca fascicularis
28%
Fowl
28%
Immune Response
14%
Virus Infectivity
14%
Mouse Model
14%
Adenoviridae
14%
Alphacoronavirus
14%
Human Coronavirus OC43
14%
Adenovirus Vaccine
14%
Human Coronavirus NL63
14%